Indonesia Vaccine Industry Outlook 2022 - 2026

Key Market Indicators

By 2026, Indonesian Vaccination Coverage is expected to reach 78 percent of children aged 1 year old, down 0.5 points year-on-year on average compared to 2021. Since 2005, it has decreased by 1.7 points year-on-year. Indonesia's Vaccine Import is expected to reach $202 million by 2026, up from $162 million in 2021, with a 3.8 percent year-on-year increase on average. Since 1994, the demand has grown by 23.4 percent year-on-year. In 2021, Indonesia ranked 24th, preceded by Russia at $162 million. The United States, United Kingdom and Germany ranked 2nd, 3rd and 4th respectively. Vaccine Export is set to reach $107 million in 2026, up 1.7 percent year-on-year on average from $98 million in 2021. Since 1994, the supply has grown at a rate of 0.9 percent year-on-year. In 2021, Indonesia ranked 19th, with Australia ahead at $98 million. Ireland, the United Kingdom and France were ranked 2nd, 3rd and 4th respectively. Vaccination Coverage of children aged 1 year old is expected to stay at 80 percent from 2021 to 2026, remaining stable on average. Since 1986, the market has remained unchanged.

Indonesia Vaccine Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends

• Pharmaceutical Innovation: Exploring Synergies in Antibiotics and Antibody Drugs Development

  Innovation in the pharmaceutical sector, specifically within antibiotics and antibody drugs, is fuelled by a multitude of factors. Increasing antimicrobial resistance necessitates the development of new antibiotics, while complex diseases like cancer and autoimmune disorders demand advanced immunotherapies. Continuous advances in technology and science also play a crucial role, alongside...

  Discover more insights

• Vaccine Market Insights: Exploring Trends in Pneumococcal and Meningococcal Immunization

  The pneumococcal vaccine market is predominantly driven by the escalating global burden of pneumococcal diseases, including pneumonia, meningitis, and sepsis. With pneumococcal bacteria as a leading cause of vaccine-preventable deaths worldwide, policymakers and health organizations are ramping up immunization drives, amplifying vaccine demand. Furthermore, the introduction of innovative vaccine variants—quelling...

  Discover more insights

• Vaccines Market: Insights into Global Trends and Emerging Forecast Practices

  Worldwide, the vaccine market is propelled forward by a combination of public health imperatives, advances in vaccine development technologies, and various market incentives. Increased rate of infectious diseases boosts the demand for vaccines, thereby expanding the markets. The swift focus on the development and distribution of COVID-19 vaccines is a...

  Discover more insights

• Travel Vaccines Market: A Comprehensive Review on Growth, Trends, and Forecast Opportunities

  The market for travel vaccines is fundamentally driven by the swelling global mobility and increased exposure to infectious diseases in developing countries. Effectively, as more people venture overseas, either due to recreational, educational, or business reasons, there is an escalated demand for specialized vaccinations. This market dynamic also reflects the...

  Discover more insights

• Global Health Initiatives: The Transformative Impact and Industry Dynamics of Dengue Vaccines

  The dengue vaccine market unravels unparalleled potential towards altering the global public health landscape. The vaccine, formulated to combat one of the most common mosquito-borne illnesses worldwide, bears significant potential to diminish morbidity and mortality. Additionally, the proliferation of such vaccines could catalyze a substantial reduction in healthcare expenses linked...

  Discover more insights